Product Information
GNP MUCUS RELIEF PE 400-10 MG is a generic product labeled by AmerisourceBergen, priced at $0.0915 per EA under NDC 46122070071. Its NADAC has been published 208 times since Oct 12, 2022.
Strength
400; 10 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122070071
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/13/2022
Pharmacological Classes
Price Statistics
The NADAC for GNP MUCUS RELIEF PE 400-10 MG has been published 208 times since Oct 12, 2022, and over the history we have for it it has risen 22.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0915 per EA |
|---|---|
| All-time high | $0.0915 (Sep 30, 2026) |
| All-time low | $0.0697 (Dec 21, 2022) |
| 52-week high | $0.0915 |
| 52-week low | $0.0740 |
| Median price | $0.0814 |
| Average price | $0.0815 |
| Largest weekly change | +16.4% (Feb 22, 2023) |
| Weeks tracked | 208 |
| Tracking since | Oct 12, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin/phenylephrine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP MUCUS RELIEF PE 400-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for GNP MUCUS RELIEF PE 400-10 MG, manufactured by AmerisourceBergen, is $0.0915 per EA (NDC 46122070071), effective Sep 30, 2026.
How has the price of GNP MUCUS RELIEF PE 400-10 MG changed over time?
Over the history we have for it, the NADAC for GNP MUCUS RELIEF PE 400-10 MG has risen 22.2%. It has been tracked across 208 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for GNP MUCUS RELIEF PE 400-10 MG?
Since Oct 12, 2022, the NADAC for GNP MUCUS RELIEF PE 400-10 MG has ranged from a low of $0.0697 (Dec 21, 2022) to a high of $0.0915 (Sep 30, 2026), with a median of $0.0814 per EA.
Are there cheaper alternatives to GNP MUCUS RELIEF PE 400-10 MG?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SM CHEST CONG RELIEF PE CAPLET, is $0.0697 per EA — about 24% below GNP MUCUS RELIEF PE 400-10 MG.
Who manufactures GNP MUCUS RELIEF PE 400-10 MG?
GNP MUCUS RELIEF PE 400-10 MG (NDC 46122070071) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.